Tue 2/25/2020 07:33 ET
DJIA27960.80995.403.56%TELCO189.521.840.97%GOLD1652.1524.451.48%Shanghai3013.0518.080.60%
S&P 5003225.90108.073.35%BANKS480.4116.333.40%OIL51.230.200.39%BITCOIN9606.1742.270.44%
NASDAQ9221.28342.113.71%PHARM602.9814.532.41%US/EU1.080.000.00%Futures3232.626.470.20%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - YM BioSciences - YMI   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add YMI
  
From: crainiac (Rep: 4158)Date: 12/07/2012 12:27
Forum: YM BioSciences - Msg #3437Thread #673482622 (Rec: 0)
in here on the dip, two presentations at ASH 2012 on Sunday, links below:

Phase I/II Study of CYT387, a JAK1/JAK2 Inhibitor for the Treatment of Myelofibrosis

https://ash.confex.com/ash/2012/webprogram/Paper51560.html

Gene Expression Profiling within the Context of JAK Inhibitor Therapy for Myelofibrosis: Correlation with Treatment Effect and Anemia Response

https://ash.confex.com/ash/2012/webprogram/Paper51276.html

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser crainiac: Reward | Watch | IgnoreYMI: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add YMI
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.